NasdaqGS · Equity Research · October 19, 2026

INTC

Intel Corporation
HOLD
PT $95
+6% upside · Low conviction
Q3 print Oct 29 — options price a ±12% moveFY27 EPS est. $2.10, up 33% in 90 daysFoundry: $293M external vs a $2.09B loss
Current Price
$89.85
Market Cap
$453.2B
52-Week High
$142.35
52-Week Low
$32.89

1-Year Price & Key Levels

Price 50-DMA 200-DMA Price target
Chart data: Yahoo Finance, as of Oct 16, 2026
$26.11$56.69$87.28$118$148NovFebMayAug Bull $140PT $95Bear $60 $89.85
RSI(14) 31.450-DMA $103200-DMA $84.56vs 52w high -36.9%52w range position 52%

Estimates Held, the Stock Didn't — Still a HOLD Into the Oct 29 Print

Intel (INTC) has round-tripped since our Sep 1 HOLD. It ran to a $127 close on Sep 24, then fell 29% to $89.85 on news and sector rotation, not on estimates. The operating story is intact: DCAI grew 59% to $6.3B in Q2, Intel beat its own EPS guide four quarters running, and FY27 consensus rose 33% to $2.10 in 90 days, with no cuts during the October selloff. The Street is warming: Barclays upgraded to Overweight and JPMorgan to Neutral, ending its four-year Underweight. What changed is the foundry narrative. Musk confirmed Terafab talks with TSMC, TSMC's CEO went after Intel's EMIB-T packaging business, and a fatal Oct 14 explosion at Kiryat Gat Fab 28 has no disclosed production impact. No external 14A customer is named and the October PDK 0.9 has not been confirmed shipped. At 42.8× FY27 EPS, still the priciest multiple on the weakest gross margin in the peer group, we trim our bull odds. HOLD, target cut $99 → $95, which is also the August offering price now acting as overhead supply.

Revenue Is Inflecting; GAAP Earnings and Cash Flow Are Not — Price as of Oct 16, 2026 close · fundamentals Q2'26 (quarter ended Jun 27, 2026)

Market Cap
$453.2B
EDGAR cover count 5.044B (Jul 24) · ≈$475B on ~5.286B shares after the August offering
Q2'26 Revenue
$16.13B
+25% YoY · up from $13.58B in Q1'26 (SEC EDGAR)
Q2'26 GAAP EPS
−$2.16
Non-GAAP $0.42 · $12.5B mark-to-market on escrowed CHIPS shares
Non-GAAP Gross Margin
41.8%
GAAP 40.4% (27.5% a year ago) · Q3 guide 42.0%
DCAI Revenue
$6.3B
+59% YoY · segment op. income $2.47B
Q2 Adj. Free Cash Flow
−$8.42B
Incl. −$12.2B net partner contributions · 2026 capex >$20B, 2027 'significantly' higher
Forward P/E
58.7× / 42.8×
FY26E $1.53 / FY27E $2.10 non-GAAP consensus (Yahoo, Oct 16)
Cash vs Debt
$29.7B / $50.5B
Jun 27 · before the ~$20B August equity raise at $95

Quarterly Revenue — SEC EDGAR (10-Q/10-K)

$13.65B
Q3 FY25
$13.67B
Q4 FY25
$13.58B
Q1 FY26
$16.13B
Q2 FY26

DCAI Is Carrying the Story While Foundry Waits for a 14A Anchor

+59%
DCAI revenue growth, Q2'26 YoY
$6.3B; CPU:GPU ratios in agentic AI moving from 1:8 toward 1:4 (CFO); server CPU lead times ~6 months
$15.8–16.8B
Q3'26 revenue guidance
42.0% non-GAAP GM, $0.38 non-GAAP EPS · Street $16.45B / $0.39 · reports Oct 29
$293M
External foundry revenue, Q2'26
Against a $2.09B Intel Foundry operating loss; no named external 14A customer
SEP 2, 2026
CFO: 14A engagements 'significantly increased'
Zinsner said customers have moved from evaluating data to asking for capacity, but no formal engagement was announced. Management says it does not intend to name foundry customers.
EARLY OCT 2026
Terafab role clouded
Musk confirmed Terafab talks with TSMC. Intel says it remains in Terafab (Oct 19), but no contract terms are disclosed. Tesla's 14A commitment dates from Apr 2026.
OCT 14–15, 2026
Kiryat Gat explosion · TSMC targets EMIB-T
A fatal gas-transfer explosion at Fab 28 (Intel 7) with no production impact disclosed. The next day TSMC's C.C. Wei said TSMC would serve customers short of Intel EMIB-T packaging capacity.
OCT 2026 (PENDING)
14A PDK 0.9 to external customers
The design kit customers need before committing. Firm supplier decisions are expected H2'26–H1'27; shipment is not confirmed as of Oct 19.
OCT 29, 2026
Q3 earnings — sixth straight beat?
Guide $15.8–16.8B, 42% non-GAAP GM, $0.38 EPS. The Q4 guide vs the $17.02B / $0.44 consensus, Fab 28 impact, external foundry revenue and 2027 capex matter more than the Q3 beat.

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus$1.53 FY26 non-GAAP (41 analysts; $1.12–$1.74) · revenue $63.2B
FY+2 EPS Consensus$2.10 FY27 non-GAAP (46 analysts; $1.45–$3.44) · revenue $72.7B
PEG Ratio~1.1× (42.8× FY27 P/E ÷ 37.8% FY27 EPS growth; our calc)
Forward P/E58.7× FY26 / 42.8× FY27
EPS Revisions (90d)↑FY26 $1.11 → $1.53 (+38%); FY27 $1.58 → $2.10 (+33%); 30 up / 0 down on the current quarter (30d) ↓2 current-quarter cuts in the last 7 days (Step-up after Q2, then flat to slightly higher since mid-August — no capitulation in the October selloff)
Guidance AccuracyBeat its own non-GAAP EPS guide four straight quarters (Q2'26 guide $0.20 vs $0.42 actual). Conservative guiding.

Earnings Surprise Track Record

Q2 2026 Est: $0.22 Act: $0.42 +95%
Q1 2026 Est: $0.01 Act: $0.29 n/m (low base)
Q4 2025 Est: $0.08 Act: $0.15 +82%
Q3 2025 Est: $0.01 Act: $0.23 n/m (low base)
Beat Rate4 of 4 (non-GAAP). Percentage beats overstate quality given ~$0.01 bases. GAAP EPS swings with the escrowed-share mark-to-market (Q2'26 −$2.16).

Insider Activity (90 Days)

Net Buying/Selling+~$10.0M: CEO Lip-Bu Tan bought 105,263 shares at $95.00 on Aug 11 (Form 4); no other transactions identified
Sell/Buy Ratio0 sells : 1 buy (90 days)
Mildly bullish but stale. There have been no Form 4s in September or October, and no insider bought the 29% pullback. The CEO's purchase is ~5% under water.
Insiders own ~0.05%. The CEO holds ~1.33M shares in total. Watch for post-blackout filings after the Oct 29 print.

Relative Valuation vs. Competitors

CompanyP/E (fwd)EV/RevRev GrowthGross Margin
Intel42.8× FY27 (58.7× FY26)~8.3× TTM+25% (Q2'26)41.8% non-GAAP
AMD31–56× (sources conflict, Oct 9)fwd P/S ~11.8×~+50% (Q2'26)56% non-GAAP
NVIDIA~20× (Oct 7)n/a+106% (Q2 FY27)75.0%
TSMC~33× trailing (Oct 9)n/a+41% USD (Q3'26)66.4%
Qualcomm19.6× (Oct 7)n/a−4% (FQ3'26)~54%
Intel trades at roughly 2× Nvidia's and Qualcomm's forward multiple, and near the top of AMD's range, with the lowest gross margin of the group and slower growth than AMD, Nvidia or TSMC. The premium pays for a foundry turnaround that still has no contracted 14A anchor. Peer multiples are mixed-date snapshots (Oct 7–9).

Price Targets & Scenarios

ScenarioPrice TargetAssumptionsProbability
14A Anchor + Clean Beat-and-Raise$140Oct 29 beats and guides Q4 above the $17.0B consensus, Fab 28 has no material impact, and a named or clearly evidenced 14A commitment (Terafab, Apple or a hyperscaler) lands by H1'27. FY27 EPS moves to ~$2.40 and the market keeps paying ~58× for 2028–29 foundry earnings. Near BofA-style $140–160 targets.20%
Server Strength, Foundry Still Unproven$98Q3 lands inside the guide at ~42% GM with a sixth beat, but Q4 is supply-constrained and 14A customers stay unnamed. FY27 EPS reaches the $2.10 consensus at ~47×. The $95 offering price caps rallies until foundry revenue climbs off the $293M base.50%
Foundry Slip + Multiple Compression$60Terafab leans to TSMC, PDK 0.9 or 14A decisions slip into 2027, Fab 28 disrupts Intel 7 output, and 2027 capex guidance forces another raise. FY27 EPS falls to ~$1.70 and the multiple compresses to ~35×, still above AMD's low end.30%

Probability-Weighted Target: $95 (≈ +6% vs $89.85 — the August $95 offering price)

$95
Weighted
Bull $14020%
Base $9850%
Bear $6030%

Analyst Consensus

JPMorgan
$85
Upgraded Underweight → Neutral — Oct 19, 2026 (ends a ~4-year Underweight)
Mizuho
$114
Neutral, PT raised from $92 — Oct 6, 2026
TD Cowen
$115
Hold reiterated — Sep 24, 2026
Barclays
n/d
Upgraded to Overweight — Sep 16, 2026 (target not disclosed in sources)
21 Buy · 28 Hold · 1 Sell — MarketBeat (50 analysts, Oct 16, incl. JPM's upgrade): consensus Hold, average target $108.48 (range $50–$200), ~21% above the price. The mix has tilted toward Buy since Sep 1 (16/31/3), but the mean target is roughly flat.

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High
$142.35
September high close (Sep 24)
$127.39
50-Day MA / $100–103 resistance
$103.17
August offering price
$95.00
Current Price
$89.85
200-Day MA (support $87–88 above)
$84.56
Low end of ±12% earnings move
≈$79
52-Week Low
$32.89

OptOptions & Sentiment

  • Implied earnings move (exp Oct 30): ±12.1% ≈ $79–$101 (OptionSlam, ~Oct 19)
  • Implied move (exp Nov 20): ±16.2%
  • Prior earnings reactions: Q2: −10.1% by expiry · Q1: +23.1% at open
  • 30-day IV: ~87%, 94th pct (Jul 8, stale — no Oct read)
  • Short interest: ~121M shares, ~1.2 days to cover (Jul 15, stale)
  • Beta: 2.22 (MarketBeat, Oct 16)
  • Volume: 146.6M on Oct 15 vs 103.7M 30-day avg

Systematic Conviction Score: 43/100 (Low)

52
Analyst Alignment
30%
20
FCF Visibility
25%
62
Catalyst Clarity
20%
22
Valuation Safety
15%
62
Mgmt Quality
10%
Weighted 0.30/0.25/0.20/0.15/0.10, the score is 43 (Low), essentially unchanged from 44. Analyst alignment (52) is mixed: ratings are tilting toward Buy and EPS revisions stayed positive through the selloff, but consensus is still Hold and JPM's 'upgrade' carries an $85 target. FCF visibility (20) is poor: −$8.4B adjusted FCF in Q2, capex rising into 2027, and FCF positive only in 2028 consensus. Catalyst clarity (62) has a hard Oct 29 date, but the load-bearing 14A commitment is undated and management won't name customers. Valuation safety (22) improved slightly as FY27 estimates rose, yet 42.8× FY27 on a 42% gross margin is still the richest in the group. Management (62): four straight guide beats and the CEO's $10M buy, offset by no disclosure yet on Fab 28 and the Terafab ambiguity.

Risk Assessment & Insider Signals

OOwnership & Insider Signals

  • U.S. government (~8.4%): 433.3M shares bought in Aug 2025 at $20.47. Passive, with no board seat. A warrant for 5% more is exercisable only if Intel cedes Foundry control, which effectively blocks a spin-off.
  • Nvidia (~4%): $5B investment; 214.8M shares on its Q1'26 13F, unchanged, with no sign of a sale.
  • SoftBank (~1.6%): 86.96M shares at the Jun 30, 2026 13F (bought at $23), about two-thirds of SoftBank's disclosed U.S. equity book. No sale reported.
  • Index and passive funds: BlackRock ~447.8M and Vanguard ~282.0M shares (Q1'26 13Fs, before the offering). Institutions own ~64.5% in total (MarketBeat).
  • August 2026 offering holders: ~210.5M shares at $95 plus a 31.6M overallotment, with reported demand above $100B. These buyers are ~5% under water, so $95 is likely overhead supply.
  • Insiders (~0.05%): The CEO holds ~1.33M shares after his $10M purchase at $95 on Aug 11.

Quantified Risk Assessment

Severity Risk Factor Prob. PT Impact
High 14A customer gap and Terafab share loss
Foundry lost $2.1B on $293M of external revenue in Q2. No external 14A customer is named, Musk confirmed Terafab talks with TSMC, and PDK 0.9 delivery is unconfirmed.
40% -20%
High Valuation de-rating around the Q3 print
42.8× FY27 EPS with beta 2.2 and a ±12% implied move. A beat that comes with a supply-constrained Q4 guide could still sell off, as Q2 did (−10% by expiry).
35% -15%
Medium Capex burn and further dilution
2026 capex is above $20B and 2027 will be 'significantly' higher. FCF is negative through 2027 in consensus, and management says it may tap capital markets again after August's ~$20B raise at $95.
30% -10%
Medium TSMC competing in advanced packaging
C.C. Wei (Oct 15) offered capacity to customers short of Intel EMIB-T. Intel's packaging revenue isn't expected to ramp until 2H27, with no named customer.
35% -8%
Medium Supply constraints and CPU share loss
The CFO said 'we will be behind in the fourth quarter.' AMD hit a record 30.3% client x86 share in Q2 (Mercury), and Diamond Rapids slipped to 2027 against AMD Venice on TSMC 2nm.
35% -8%
Medium Kiryat Gat Fab 28 disruption
The Oct 14 explosion during an NF3 gas transfer killed two workers. Intel has disclosed no equipment or production impact, and the Q3 call is the first chance to.
20% -5%

Summary

Rating
HOLD
Conviction
Low
Price Target
$95
Timeframe
12 mo
Upside
+6%
Position Size
0%–3%

Entry Strategy

1
Tranche 1 — 25%
≈$90
A starter only. Revisions held through the selloff and the Street is turning, but the Oct 29 print carries a ±12% implied move, so keep the pre-print position small.
2
Tranche 2 — 35%
≈$84.50
Add at the 200-DMA if the print is clean (Q4 guide near $17B, no material Fab 28 hit). It also puts the cost base ~11% below the $95 offering overhang.
3
Tranche 3 — 40%
≈$79
The low end of the implied earnings move. Deploy only if external foundry revenue is growing off $293M and 14A/Terafab hasn't visibly gone to TSMC. Otherwise the thesis has changed, so cancel.
DATA PROVENANCE: Figures as of Oct 19, 2026 (price as of Oct 16 close). Next catalyst: Q3 2026 earnings — Thu Oct 29, 2026 after close (confirmed by Intel IR, Oct 6) · options imply ±12% · 14A PDK 0.9 due in October (not yet confirmed shipped). Primary sources: SEC EDGAR 10-Q/10-K (CIK 0000050863) · Yahoo Finance quote & history · Intel IR — Q3 2026 results date (Oct 6, 2026) · Yahoo/TIKR — Intel fell nearly 6% as TSMC took aim at packaging (Oct 16, 2026). Hard figures are sourced from the filings above; targets and ratings are interpretation, not a guarantee.
IMPORTANT DISCLAIMER: This analysis is for educational and research purposes only. Not financial advice. Past performance does not guarantee future results. Consult qualified financial professionals before making investment decisions. All investments carry risk of loss. The information presented is based on publicly available data as of October 19, 2026.